Related Experiment Videos

Respiratory syncytial virus-related apnea in infants. Demographics and outcome

Insights

Respiratory syncytial virus (RSV) infection causes apnea in 18% of infants, particularly premature newborns. While RSV apnea is linked to prematurity, it doesn't increase later apnea risk.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Neonatology

Background:

  • Respiratory syncytial virus (RSV) is a common cause of respiratory illness in infants.
  • Apnea, or pauses in breathing, is a known complication in infants, especially premature ones.
  • The relationship between RSV infection and apnea requires further investigation.

Purpose of the Study:

  • To determine the incidence of RSV-associated apnea in hospitalized infants.
  • To identify risk factors for developing apnea during RSV infection.
  • To assess the risk of subsequent apnea or death in infants with RSV-associated apnea.

Main Methods:

  • Retrospective review of medical records for 261 hospitalized infants under one year old with confirmed RSV infection.
  • Analysis of patient demographics, gestational age, postnatal age, and history of apnea.
  • Statistical evaluation to identify risk factors and subsequent outcomes.

Main Results:

  • 18% of infants with RSV infection experienced apnea.
  • Premature birth and young postnatal age were significant risk factors for RSV-associated apnea.
  • Infants born at or before 32 weeks gestational age with apnea of prematurity were at higher risk for RSV apnea.
  • Infants with RSV apnea did not show an increased risk for subsequent apnea.
  • Two of the 48 infants with RSV apnea died within the first year of life.

Conclusions:

  • RSV-associated apnea in hospitalized infants may stem from immature respiratory drive.
  • Prematurity is a key risk factor for developing apnea with RSV infection.
  • While RSV apnea itself may not increase future apnea risk, close monitoring is crucial due to potential mortality.

Related Concept Videos